Suppr超能文献

慢性特发性血小板减少性紫癜患者血清抗糖蛋白的免疫球蛋白类别、特异性及滴度谱

Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura.

作者信息

He R, Reid D M, Jones C E, Shulman N R

机构信息

Clinical Hematology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892.

出版信息

Blood. 1994 Feb 15;83(4):1024-32.

PMID:8111044
Abstract

The characteristic decreased recovery and survival of transfused platelets in nonalloimmunized patients with idiopathic thrombocytopenic purpura (ITP) suggest that plasma antiplatelet autoantibodies (autoAbs) are present in almost all cases. Studies emphasizing reactions of IgG autoAbs with platelet glycoprotein (GP) IIb/IIIa indicate that less than 50% of ITP patients have detectable serum Abs, and that many of these Abs may not be pathogenic because they are directed against epitopes in the cytoplasmic domain of GPIIIa (Fujisawa et al, Blood 77:2207, 1991 and 79:1441, 1992). We evaluated the contribution of Ig classes other than IgG to the overall incidence of serum Abs in 47 patients with chronic ITP and the frequency of reactions with GPs IIb/IIIa, Ib/IX, IV, and Ia/IIa. Abs were further characterized by their reactions with cytosolic or exosolic GP epitopes and their titers and apparent affinities. Using immunobead techniques we found (1) anti-GPs in 85% of sera; (2) IgA and IgG Abs each in 68%, together in 51%; (3) IgM agglutinins in 15%, always with another Ab class; (4) GP Ib/IX, IIb/IIIa, IV, and Ia/IIa targets in 83%, 81%, 38%, and 28% of cases, respectively; (5) 93% of positive sera reactive with more than one GP; but GP IV or Ia/IIa never the sole target; (6) Abs against cytosolic epitopes on one or more of GPs IIIa, Ib alpha, and IIb beta in 66% of sera, always accompanied by Abs against exosolic epitopes of the same or a different GP; (7) autoAbs against cytosolic GP epitopes in 38% of 16 patients recovered from posttransfusion purpura and drug purpura; and (8) evidence that serum ITP Abs, often high-titered, saturate platelets less than alloAbs against the same GPs. Whereas Abs against external GP epitopes are a distinctive marker for ITP in 80% of patients, Abs against internal GP epitopes are likely a secondary phenomenon of platelet destruction and not pathogenic. Anti-GPs against exosolic epitopes were also found in eluates of patient's platelets, suggesting that they have pathogenic significance.

摘要

特发性血小板减少性紫癜(ITP)非同种免疫患者中,输注血小板的恢复和存活特征性降低,这表明几乎所有病例中都存在血浆抗血小板自身抗体(自身抗体)。强调IgG自身抗体与血小板糖蛋白(GP)IIb/IIIa反应的研究表明,不到50%的ITP患者血清中有可检测到的抗体,而且其中许多抗体可能没有致病性,因为它们针对的是GPIIIa胞质结构域中的表位(藤泽等人,《血液》77:2207,1991年和79:1441,1992年)。我们评估了除IgG外其他Ig类别对47例慢性ITP患者血清抗体总发生率的贡献,以及与GP IIb/IIIa、Ib/IX、IV和Ia/IIa反应的频率。通过它们与胞质或胞外表位的反应、滴度和表观亲和力对抗体进行进一步表征。使用免疫珠技术,我们发现:(1)85%的血清中有抗GP抗体;(2)IgA和IgG抗体各占68%,两者同时存在的占51%;(3)IgM凝集素占15%,总是与另一类抗体同时存在;(4)分别有83%、81%、38%和28%的病例中,GP Ib/IX、IIb/IIIa、IV和Ia/IIa为靶点;(5)93%的阳性血清与一种以上的GP反应;但GP IV或Ia/IIa从未是唯一靶点;(6)66%的血清中有针对一种或多种GP(IIIa、Ibα和IIbβ)胞质表位的抗体,总是伴有针对相同或不同GP胞外表位的抗体;(7)16例从输血后紫癜和药物性紫癜中康复的患者中,38%有针对胞质GP表位的自身抗体;(8)有证据表明,血清ITP抗体(通常滴度较高)使血小板饱和的程度低于针对相同GP的同种抗体。虽然针对胞外表位的抗体在80%的患者中是ITP的独特标志物,但针对胞内GP表位的抗体可能是血小板破坏的继发现象,没有致病性。在患者血小板洗脱物中也发现了针对胞外表位的抗GP抗体,这表明它们具有致病意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验